StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.45+0.30 (+13.95%)

Close on Nov 17, 2026Market cap $106.07MP/E –Yield –

NRX Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

NRX Pharmaceuticals's gross margin for the twelve months ending Jun 30, 2026 was 46.6%. For fiscal 2025 it was 58.8%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202558.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202638.7%–
Q1 FY2026Mar 31, 202640.9%–
Q4 FY2025Dec 31, 202558.5%–
Q3 FY2025Sep 30, 202559.9%–

More NRX Pharmaceuticals figures

See a number that looks wrong?